Home › Chronic Myelomonocytic Leukemia › Georgia
Chronic Myelomonocytic Leukemia clinical trials in Georgia
4 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in Georgia.
Cities in Georgia
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Winship Cancer Institute - Emory University, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
- Winship Cancer Institute at Emory, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07033598Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- Emory University, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07143669A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- University of Emory - Winship Cancer Institute, Atlanta
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.